Eudaimonia Asset Management »

Diamedica Therapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $548k 213k 2.58
2023-06-30 $1.2M 270k 4.32
2021-03-31 $990k 108k 9.15
2020-12-31 $1.1M 110k 10.14

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Kratos Defense & Security Solutions Common Stock (KTOS)
Sterling Infrastructure Common Stock (STRL)
Primoris Services Corp Common Stock (PRIM)
Rambus Common Stock (RMBS)
IonQ Common Stock (IONQ)
TTM Technologies Common Stock (TTMI)
Advanced Energy Industries Common Stock (AEIS)
Blackrock Funds - Equities ETF (SMIN)
Fabrinet Common Stock (FN)
nLight Common Stock (LASR)
SPX Technologies Common Stock (SPXC)
AeroVironment Common Stock (AVAV)
Bloom Energy Corp Common Stock (BE)
Talen Energy Corp Common Stock (TLN)

View all positions for Eudaimonia Asset Management

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Millennium Management
Paragon Associates & Paragon Associates Ii Joint Venture
Geode Capital Management
Vanguard Group
First Manhattan
State Street Corporation
Bleichroeder
Northern Trust
LPL Financial
Advisor Group Holdings
CI Private Wealth
Corient IA
Cantor Fitzgerald, L. P.

View all funds holding Diamedica Therapeutics